Clinical Trial Update: Evaluation of Treatment and Prophylaxis of Invasive Fungal Infections in Immuncompromised Patients in Austria (Study P05532)(WITHDRAWN)

View source ↗

Summary

A Merck-sponsored clinical trial evaluating treatment and prophylaxis of invasive fungal infections in immunocompromised patients in Austria has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycoses

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Mycoses | Status: WITHDRAWN